BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2185785)

  • 1. Liposomes as carrier and immunoadjuvant of vaccine antigens.
    van Rooijen N
    Adv Biotechnol Processes; 1990; 13():255-79. PubMed ID: 2185785
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunological adjuvant and vaccine carrier properties of liposomes.
    Gregoriadis G
    J Drug Target; 1994; 2(5):351-6. PubMed ID: 7704478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel vaccine delivery system using immunopotentiating fusogenic liposomes.
    Hayashi A; Nakanishi T; Kunisawa J; Kondoh M; Imazu S; Tsutsumi Y; Tanaka K; Fujiwara H; Hamaoka T; Mayumi T
    Biochem Biophys Res Commun; 1999 Aug; 261(3):824-8. PubMed ID: 10441509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal vaccine delivery systems.
    Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
    Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ISCOMATRIX adjuvant for antigen delivery.
    Pearse MJ; Drane D
    Adv Drug Deliv Rev; 2005 Jan; 57(3):465-74. PubMed ID: 15560952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic liposomes as vaccine adjuvants.
    Christensen D; Korsholm KS; Rosenkrands I; Lindenstrøm T; Andersen P; Agger EM
    Expert Rev Vaccines; 2007 Oct; 6(5):785-96. PubMed ID: 17931158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes as carriers of antigens and adjuvants.
    Alving CR
    J Immunol Methods; 1991 Jun; 140(1):1-13. PubMed ID: 1712030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.
    Felnerova D; Viret JF; Glück R; Moser C
    Curr Opin Biotechnol; 2004 Dec; 15(6):518-29. PubMed ID: 15560978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes as carriers of antigens as well as other molecules involved in immunity.
    Rouse BT
    J Am Vet Med Assoc; 1982 Nov; 181(10):988-91. PubMed ID: 6757219
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model.
    Faisal SM; Yan W; McDonough SP; Chang CF; Pan MJ; Chang YF
    Vaccine; 2009 Nov; 27(47):6537-45. PubMed ID: 19729088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomaterials as vaccine adjuvants.
    Jones KS
    Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response.
    Zigterman GJ; Snippe H; Jansze M; Willers JM
    J Immunol; 1987 Jan; 138(1):220-5. PubMed ID: 3782798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen.
    Su D; Van Rooijen N
    Immunology; 1989 Mar; 66(3):466-70. PubMed ID: 2703258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as immunological adjuvants.
    van Rooijen N; van Nieuwmegen R; Kors N
    Prog Clin Biol Res; 1982; 102 pt A():281-90. PubMed ID: 6188165
    [No Abstract]   [Full Text] [Related]  

  • 17. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO; Somavarapu S; Atuah KN; Bramwell VW
    Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid A and liposomes containing lipid A as antigens and adjuvants.
    Alving CR; Rao M
    Vaccine; 2008 Jun; 26(24):3036-45. PubMed ID: 18226433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations.
    Miles AP; McClellan HA; Rausch KM; Zhu D; Whitmore MD; Singh S; Martin LB; Wu Y; Giersing BK; Stowers AW; Long CA; Saul A
    Vaccine; 2005 Mar; 23(19):2530-9. PubMed ID: 15752840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages.
    van Rooijen N
    J Drug Target; 2008 Aug; 16(7):529-34. PubMed ID: 18686122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.